Pulmodyne, with offices and factory at 2055 Executive Drive, near the Indianapolis International Airport, has been expanding in recent years to meet a skyrocketing number of orders from the COVID-19 pandemic.
Sunnyvale, California-based Gener8 LLC has acquired RND Group, a 25-year-old software development firm headquartered in Indianapolis, the companies announced.
Orano Med LLC says the facility will be used to manufacture and distribute radiopharmaceuticals to treat cancer at hospitals throughout the country.
Coy, who has been at the organization since 2017, overseeing the first phase of development at the 50-acre 16 Tech Innovation District, is stepping down after a long career in economic development.
Genezen said the 75,000-square-foot addition will triple its current footprint.
Genome & Co. announced Thursday morning that it plans to establish a new 110,000-square-foot facility on 15 acres in the new Fishers Life Science & Innovation Park.
Indianapolis-based Langham Logistics said the facility will be dedicated to pharmaceutical, vaccine and biologics manufacturing and distribution clients.
The Indianapolis-based drugmaker said the deal to buy Protomer Technologies could be worth up to $1 billion if the technology meets certain milestones. Lilly did not say how much it was paying up front in cash.
The radiopharmaceutical developer and manufacturer is the latest in a string of life sciences firms that have announced plans to grow operations in Fishers.
The new gadget from VoCare Inc. is about the size of a smart phone and measures a person’s temperature, heart rate, blood pressure, blood glucose levels, blood oxygen saturation and heart rhythms.
Fishers-based Quantigen Biosciences is spending $2.5 million to redevelop 40,000 square feet of office space along Interstate 69 as its new specialty contract research laboratory.
Much of the money is earmarked to acquire a 75-acre property for a life sciences business park that will be anchored by Stevanato Group’s planned $145 million pharmaceutical manufacturing facility.
Stevanato Group, a producer of syringes, vials and glass containers, announced Wednesday it will spend $145 million to build and equip a 370,000-square-foot facility in Fishers.
Several tons of salmon, engineered by biotech company AquaBounty Technologies Inc. and raised in Indiana, are heading to restaurants and dining services for the first time.
The company, with headquarters and a massive factory on the northwest side, has hired about 100 people in the past year, bringing its workforce to about 550. And it’s looking to hire another 100 people this year.
Matthew Sause took the helm of the 4,500-person Roche Diagnostics’ North American operations in Indianapolis in November 2019—just four months before the World Health Organization declared a pandemic and much of the planet went into lockdown.
This is a partial transcript of IBJ’s annual Life Sciences Power Panel, which took place virtually on April 30 with four of Indy’s biosciences leaders: 16 Tech CEO Bob Coy, GenePace Laboratories founder Sanjay Malkani, Elanco Animal Health CEO Jeff Simmons and Indiana University School of Medicine geneticist Tatiana Foroud.
Speakers at the IBJ Life Sciences Power Panel on Friday said their organizations have largely weathered the lockdown—raising records funds, taking on huge expansions, hiring new employees and reporting higher productivity.
The expansion will consist of 32 new one-bedroom apartments and five two-bedroom residences, bringing to 67 the number of assisted-living apartments at the complex.
The legislation, Senate Bill 202, would allow designated family members to visit residents under end-of-life and other serious circumstances.
